NCT00468975View on ClinicalTrials.gov

A Blinded Study To Examine The Ability Of PF-610,355 To Open The Airways In Asthmatic Patients.

PHASE2CompletedINTERVENTIONAL

Enrollment

42

Participants

Timeline

Start Date

May 31, 2007

Conditions

Asthma

Interventions

DRUG

PF-610,355

DRUG

Salmeterol

Trial Locations (6)

14050

Pfizer Investigational Site, Berlin

22927

Pfizer Investigational Site, Großhansdorf

65187

Pfizer Investigational Site, Wiesbaden

413 45

Pfizer Investigational Site, Gothenburg

221 85

Pfizer Investigational Site, Lund

M23 9QZ

Pfizer Investigational Site, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT00468975 - A Blinded Study To Examine The Ability Of PF-610,355 To Open The Airways In Asthmatic Patients. | Biotech Hunter | Biotech Hunter